StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pre-Open Stock Movers 07/26: (EXAS) (CRY) (NFLX) Higher; (TKAI) (CRME) (MSTX) (NDLS) (MBLY) Lower (more...)
July 26, 2016 9:32 AM
Today's Pre-Open Stock MoversTokai Pharmaceuticals Inc. (Nasdaq: TKAI) 69% LOWER; announced that it plans to discontinue the ARMOR3-SV clinical trial ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Special Reports
Next Articles
Needham & Company Reiterates Buy as Sanmina (SANM) Shares Sell Off; Sees Weakness as Buying Opportunity
July 27, 2016 3:37 PM
UBS Reiterates Buy on McDonald's (MCD) Following 2Q
July 27, 2016 9:37 AM
UBS Raises Price Target on Masco Corp. (MAS) Following 2Q Report - PT to $40
July 27, 2016 9:30 AM
Jefferies Reiterates Hold on McDonald's (MCD) Following 2Q
July 27, 2016 8:47 AM
Jefferies Remains Sidelined on Noodles & Company (NDLS) Following 2Q and CEO Departure
July 27, 2016 8:43 AM
RBC Capital Updates Estimates on McDonald's (MCD) Following 2Q; Reiterates Outperform
July 27, 2016 7:53 AM
FBR Capital Raises Price Target on Sirius XM (SIRI) and Updates Model Following 2Q
July 27, 2016 7:34 AM
BMO Capital Downgrades Tokai Pharmaceuticals (TKAI) to Market Perform
July 26, 2016 10:43 AM
Stifel Downgrades Tokai Pharmaceuticals (TKAI) to Hold
July 26, 2016 9:45 AM
